Jazz Pharmaceuticals (JAZZ) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Jazz Pharmaceuticals

    NASDAQ: JAZZ · Real-Time Price · USD
    129.50
    1.48 (1.16%)
    At close: Sep 05, 2025, 3:59 PM
    129.50
    0.00%
    After-hours: Sep 05, 2025, 04:10 PM EDT

    Jazz Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 4.07B 3.83B 3.66B 3.09B
    Cost of Revenue
    		 445.71M 435.58M 540.52M 440.76M
    Gross Profit
    		 3.62B 3.4B 3.12B 2.65B
    Operating Income
    		 716.63M 578.58M -65.53M 170.28M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 468.69M 294.92M -382.7M -113.55M
    Net Income
    		 560.12M 414.83M -224.06M -328.95M
    Selling & General & Admin
    		 1.39B 1.34B 1.42B 1.45B
    Research & Development
    		 884M 849.66M 590.45M 505.75M
    Other Expenses
    		 637.31M 627.28M 1.18B 525.77M
    Operating Expenses
    		 2.91B 2.82B 3.18B 2.48B
    Interest Expense
    		 238.1M 289.44M 288.24M 278.77M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 3.35B 3.26B 3.72B 2.92B
    Income Tax Expense
    		 -91.43M -119.91M -158.65M 216.12M
    Shares Outstanding (Basic)
    		 61.84M 63.29M 62.54M 59.69M
    Shares Outstanding (Diluted)
    		 66.01M 72.07M 62.54M 59.69M
    EPS (Basic)
    		 9.06 6.55 -3.58 -5.51
    EPS (Diluted)
    		 8.65 6.10 -3.58 -5.51
    EBITDA
    		 1.52B 1.45B 1.47B 1.03B
    EBIT
    		 861.64M 810.73M 839.14M 475.26M
    Depreciation & Amortization
    		 660.07M 638.7M 629.47M 552.48M

    Add to Watchlist